Lmr Partners LLP Oramed Pharmaceuticals Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.88 - $12.03 $26,842 - $54,916	4,565 Added 34.31%	17,872 $215,000
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $49,502 - $119,763	13,307 New	13,307 $61,000
Q1 2021 May 17, 2021	SELL	$4.22 - $11.33 $97,452 - $261,643	-23,093 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.48 - $4.64 $24,544 - $45,922	-9,897 Reduced 30.0%	23,093 $98,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $4.12 $94,681 - $135,918	32,990 New	32,990 $116,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.